Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

11-Jun-18 - 09-Jun-19
Buy Ratio:34%

Down

# Net Buyers:101
# Net Sellers:194

Previous 52 Weeks

12-Jun-17 - 10-Jun-18
Buy Ratio:35%
# Net Buyers:108
# Net Sellers:203
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Juno Therapeutics, Inc.--$1.50B  
Kite Pharma, Inc.--$698.42M  
Corium International, Inc.$297.94M$299.46M  
Sucampo Pharmaceuticals, Inc.--$209.03M  
Madrigal Pharmaceuticals, Inc.$1.22M$140.42M  
New Net Buyers
CompanyNet Buy AmountChange
Corium International, Inc.$297.94M$299.46M  
Madrigal Pharmaceuticals, Inc.$1.22M$140.42M  
Portola Pharmaceuticals Inc$4.47M$41.15M  
Acadia Pharmaceuticals Inc$22.45M$32.56M  
Galectin Therapeutics Inc$17.33M$25.41M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Tesaro, Inc.($3.37B)($3.38B)  
Loxo Oncology, Inc.($853.02M)($690.35M)  
Eli Lilly & Co($569.03M)($341.00M)  
Osiris Therapeutics, Inc.($281.65M)($281.65M)  
Seattle Genetics Inc /wa($27.23M)($275.83M)  
New Net Sellers
CompanyNet Buy AmountChange
Tesaro, Inc.($3.37B)($3.38B)  
Seattle Genetics Inc /wa($27.23M)($275.83M)  
Merck & Co., Inc.($190.44M)($191.54M)  
Intercept Pharmaceuticals, Inc.($83.39M)($91.01M)  
Immune Design Corp.($42.92M)($54.63M)